Class information for:
Level 1: GV1001//PA MSHA VACCINE//HTERTC27

Basic class information
Class id #P Avg. number of
references		 Database coverage
of references
25112 291 46.9 85%


Bar chart of Publication_year

Last years might be incomplete

Hierarchy of classes
The table includes all classes above and classes immediately below the current class.


Cluster id Level Cluster label #P
0 4 BIOCHEMISTRY & MOLECULAR BIOLOGY//CELL BIOLOGY//ONCOLOGY 4064930
10 3       IMMUNOLOGY//JOURNAL OF IMMUNOLOGY//IMMUNOL 134299
140 2             IMMUNOTHERAPY//DENDRITIC CELLS//CANCER IMMUNOLOGY IMMUNOTHERAPY 23462
25112 1                   GV1001//PA MSHA VACCINE//HTERTC27 291

Terms with highest relevance score


rank Term termType Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with
term in
class
1 GV1001 authKW 472191 2% 75% 6
2 PA MSHA VACCINE authKW 314796 1% 100% 3
3 HTERTC27 authKW 291474 2% 56% 5
4 TETRASTIGMA HEMSLEYANUM authKW 285640 2% 39% 7
5 BELAGENPUMATUCEL L authKW 239841 1% 57% 4
6 L BLP25 authKW 218603 2% 42% 5
7 RADIX TETRASTIGMA authKW 209864 1% 100% 2
8 UNITE VIROL MOL VECTOROL address 209864 1% 100% 2
9 VAXON BIOTECH address 209864 1% 100% 2
10 PA MSHA authKW 167887 1% 40% 4

Web of Science journal categories


Rank Term Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with
term in
class
1 Oncology 2947 52% 0% 151
2 Immunology 569 22% 0% 65
3 Medicine, Research & Experimental 290 13% 0% 37
4 Respiratory System 172 7% 0% 20
5 Biotechnology & Applied Microbiology 165 11% 0% 33
6 Cell & Tissue Engineering 30 1% 0% 3
7 Hematology 21 3% 0% 10
8 Pharmacology & Pharmacy 12 7% 0% 19
9 Genetics & Heredity 9 4% 0% 11
10 Chemistry, Medicinal 9 2% 0% 7

Address terms


Rank Term Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with
term in
class
1 UNITE VIROL MOL VECTOROL 209864 1% 100% 2
2 VAXON BIOTECH 209864 1% 100% 2
3 ABT ONKOL WERPUNKT 104932 0% 100% 1
4 BATIMENT INSERM LAVOISIER 104932 0% 100% 1
5 BIOENGN ROBOT SYST ENGN 104932 0% 100% 1
6 BIOMODELS UNIT 104932 0% 100% 1
7 BUSINESS PROJECTS DEV 104932 0% 100% 1
8 CANC CARE ONTARIO REG PARTNER 104932 0% 100% 1
9 CANC HOSPBREAST CANC ONCOL 104932 0% 100% 1
10 CAS FS BIOTECH PHARMACEUT 104932 0% 100% 1

Journals


Rank Term Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with
term in
class
1 MEDICC REVIEW 8923 1% 2% 4
2 CLINICAL LUNG CANCER 4965 2% 1% 6
3 ONCOIMMUNOLOGY 3944 2% 1% 6
4 INTERFERON Y BIOTECNOLOGIA 3746 0% 4% 1
5 JOURNAL OF THORACIC ONCOLOGY 3165 3% 0% 9
6 EXPERT REVIEW OF VACCINES 3027 2% 0% 6
7 HUMAN VACCINES & IMMUNOTHERAPEUTICS 2230 2% 0% 6
8 CANCER IMMUNOLOGY IMMUNOTHERAPY 1945 3% 0% 9
9 CANCER GENE THERAPY 1919 2% 0% 6
10 CLINICAL CANCER RESEARCH 1575 5% 0% 15

Author Key Words


Rank Term Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with
term in
class		 LCSH search Wikipedia search
1 GV1001 472191 2% 75% 6 Search GV1001 Search GV1001
2 PA MSHA VACCINE 314796 1% 100% 3 Search PA+MSHA+VACCINE Search PA+MSHA+VACCINE
3 HTERTC27 291474 2% 56% 5 Search HTERTC27 Search HTERTC27
4 TETRASTIGMA HEMSLEYANUM 285640 2% 39% 7 Search TETRASTIGMA+HEMSLEYANUM Search TETRASTIGMA+HEMSLEYANUM
5 BELAGENPUMATUCEL L 239841 1% 57% 4 Search BELAGENPUMATUCEL+L Search BELAGENPUMATUCEL+L
6 L BLP25 218603 2% 42% 5 Search L+BLP25 Search L+BLP25
7 RADIX TETRASTIGMA 209864 1% 100% 2 Search RADIX+TETRASTIGMA Search RADIX+TETRASTIGMA
8 PA MSHA 167887 1% 40% 4 Search PA+MSHA Search PA+MSHA
9 MAGE A3 125395 2% 17% 7 Search MAGE+A3 Search MAGE+A3
10 ADOPTIVE IMMUNE SYSTEM 104932 0% 100% 1 Search ADOPTIVE+IMMUNE+SYSTEM Search ADOPTIVE+IMMUNE+SYSTEM

Core articles
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c:
(1) Number of references referring to publications in the class.
(2) Share of total number of active references referring to publications in the class.
(3) Age of the article. New articles get higher score than old articles.
(4) Citation rate, normalized to year.


Rank Reference # ref.
in cl.		 Shr. of ref. in
cl.		 Citations
1 LIU, JP , CHEN, WS , SCHWARER, AP , LI, H , (2010) TELOMERASE IN CANCER IMMUNOTHERAPY.BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER. VOL. 1805. ISSUE 1. P. 35-42 29 38% 36
2 VONDERHEIDE, RH , (2008) PROSPECTS AND CHALLENGES OF BUILDING A CANCER VACCINE TARGETING TELOMERASE.BIOCHIMIE. VOL. 90. ISSUE 1. P. 173-180 30 36% 22
3 MA, K , TANG, YH , (2014) THERAPEUTIC VACCINES EXPLORED IN PATIENTS WITH NON-SMALL CELL LUNG CANCER.ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY. VOL. 14. ISSUE 2. P. 256 -264 25 31% 3
4 WANG, M , CAO, JX , LIU, YS , XU, BL , LI, D , ZHANG, XY , LI, JL , LIU, JL , WANG, HB , WANG, ZX , (2015) EVALUATION OF TUMOUR VACCINE IMMUNOTHERAPY FOR THE TREATMENT OF ADVANCED NON-SMALL CELL LUNG CANCER: A SYSTEMATIC META-ANALYSIS.BMJ OPEN. VOL. 5. ISSUE 4. P. - 16 46% 2
5 THORN, M , WANG, MJ , KLOVERPRIS, H , SCHMIDT, EGW , FOMSGAARD, A , WENANDY, L , BERNTSEN, A , BRUNAK, S , BUUS, S , CLAESSON, MH , (2007) IDENTIFICATION OF A NEW HTERT-DERIVED HLA-A*0201 RESTRICTED, NATURALLY PROCESSED CTL EPITOPE.CANCER IMMUNOLOGY IMMUNOTHERAPY. VOL. 56. ISSUE 11. P. 1755-1763 15 60% 10
6 CARPENTER, EL , VONDERHEIDE, RH , (2006) TELOMERASE-BASED IMMUNOTHERAPY OF CANCER.EXPERT OPINION ON BIOLOGICAL THERAPY. VOL. 6. ISSUE 10. P. 1031-1039 22 40% 17
7 PALMA, M , CHOUDHURY, A , MELLSTEDT, H , (2009) CANCER VACCINES FOR NON-SMALL-CELL LUNG CANCER.MINERVA CHIRURGICA. VOL. 64. ISSUE 6. P. 643 -653 16 52% 1
8 ZANETTI, M , (2017) A SECOND CHANCE FOR TELOMERASE REVERSE TRANSCRIPTASE IN ANTICANCER IMMUNOTHERAPY.NATURE REVIEWS CLINICAL ONCOLOGY. VOL. 14. ISSUE 2. P. 115 -128 34 20% 0
9 FENOGLIO, D , PARODI, A , LAVIERI, R , KALLI, F , FERRERA, F , TAGLIAMACCO, A , GUASTALLA, A , LAMPERTI, MG , GIACOMINI, M , FILACI, G , (2015) IMMUNOGENICITY OF GX301 CANCER VACCINE: FOUR (TELOMERASE PEPTIDES) ARE BETTER THAN ONE.HUMAN VACCINES & IMMUNOTHERAPEUTICS. VOL. 11. ISSUE 4. P. 838 -850 15 39% 5
10 CHEN, DY , VANCE, BA , THOMPSON, LBS , DOMCHEK, SM , VONDERHEIDE, RH , (2007) DIFFERENTIAL LYSIS OF TUMORS BY POLYCLONAL T CELL LINES AND T CELL CLONES SPECIFIC FOR HTERT.CANCER BIOLOGY & THERAPY. VOL. 6. ISSUE 12. P. 1991-1996 12 63% 13

Classes with closest relation at Level 1


Rank Class id link
1 24888 CANC VACCINE DEV//INNOVAT CANC THER Y//PERSONALIZED PEPTIDE VACCINE
2 1375 CANCER TESTIS ANTIGEN//NY ESO 1//MAGE
3 26564 RAS DERIVED PEPTIDES//P53 PEPTIDES//RAS PEPTIDES
4 13629 TUMOR IMMUNOL BIOL//SIPULEUCEL T//5T4
5 16780 CANC VACCINE DEV PROGRAM//CANC IMMUNOL IMMUNOTHER Y//TUMOR VACCINE GRP
6 20004 CYTOKINE INDUCED KILLER CELLS//CIK CELLS//CIK
7 28487 ADJUVANT SPECIFIC IMMUNOTHERAPY//CHEMOTACTIC INHIBITORS//CHIMERIC ANTIBODY 311
8 13573 IMMUNOGENIC CELL DEATH//U1015//U805
9 217 TELOMERASE//HTERT//TELOMERASE ACTIVITY
10 8124 TUMOR VACCINE//GENE THERAPY//B71

Go to start page